Leo Pharma has no doubts about where the road ahead is leading it. By the end of the decade, the company aims to be one of the absolute biggest international organizations within medical dermatology, and is currently going through sweeping changes to get there.
”These are very exciting times at Leo. We are in the middle of an important transformation,” says Jörg Möller, who just celebrated his first year as head of global research and development at Leo Pharma after spending 20 years at Bayer.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app